Zhejiang Medicine Co Ltd (600216)

Currency in CNY
10.11
-0.30(-2.88%)
Delayed Data·
Trading near 52-week Low
600216 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.1010.33
52 wk Range
10.1018.58
Key Statistics
Bid/Ask
10.10 / 10.11
Prev. Close
10.41
Open
10.33
Day's Range
10.1-10.33
52 wk Range
10.1-18.58
Volume
4.26M
Average Volume (3m)
15.98M
1-Year Change
-28.903%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600216 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.10
Upside
+39.47%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 14.10
(+39.47% Upside)

Earnings

Latest Release
Oct 28, 2026
EPS / Forecast
0.09 / 0.28
Revenue / Forecast
1.86B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.66
Dividend Yield
2.67%
Industry Median 1.85%
Annualized payout
0.28
Paid annually
5-Years Growth
+4.01%
Growth Streak

600216 Income Statement

Compare 600216 to Peers and Sector

Metrics to compare
600216
Peers
Sector
Relationship
P/E Ratio
15.6x18.7x−0.2x
PEG Ratio
−0.320.130.00
Price/Book
0.9x2.3x2.6x
Price / LTM Sales
1.2x2.7x2.7x
Upside (Analyst Target)
38.1%19.9%72.2%
Fair Value Upside
Unlock24.5%12.4%Unlock

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceuticals products in China and internationally. The company offers synthetic vitamin E, vitamin A, natural vitamin E, ß-carotene, canthaxanthin, vancomycin hydrochloride, teicoplanin, and daptomycin. It also provides fat-soluble vitamins, quinolone antibiotics, anti-drug-resistant antibiotics, and other products, as well as animal nutrition products. In addition, the company offers injectable levofloxacin lactate, vancomycin hydrochloride injection, and injectable teicoplanin products. The company was incorporated in 1997 and is headquartered in Shaoxing, China.

Employees
5417
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
57.08M6.02%597.65M
Other Institutional Investors
369.42M38.97%3.87B
Public Companies & Retail Investors
521.41M55.01%5.46B
Total
947.91M100.00%9.92B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Xinchang Changxin Investment Development Ltd.21.96%208,192,3612,179,774
SDIC Hi-tech Investment Co., Ltd15.84%150,127,5731,571,836

People Also Watch

22.64
601899
-5.19%
32.25
601601
-0.65%
59.56
600183
-1.21%
6.37
000425
-2.30%
10.60
601012
-3.20%

FAQ

What Is the Zhejiang Medicine (600216) Stock Price Today?

The Zhejiang Medicine stock price today is 10.11 CNY.

What Stock Exchange Does Zhejiang Medicine Trade On?

Zhejiang Medicine is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Zhejiang Medicine?

The stock symbol for Zhejiang Medicine is "600216."

Does Zhejiang Medicine Pay Dividends? What’s The Current Dividend Yield?

The Zhejiang Medicine dividend yield is 2.7%%.

What Is the Zhejiang Medicine Market Cap?

As of today, Zhejiang Medicine market cap is 9.58B CNY.

What Is Zhejiang Medicine's Earnings Per Share (TTM)?

The Zhejiang Medicine EPS (TTM) is 0.66.

When Is the Next Zhejiang Medicine Earnings Date?

Zhejiang Medicine will release its next earnings report on Apr 28, 2027.

From a Technical Analysis Perspective, Is 600216 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Zhejiang Medicine Stock Split?

Zhejiang Medicine has split 4 times.

How Many Employees Does Zhejiang Medicine Have?

Zhejiang Medicine has 5417 employees.

What is the current trading status of Zhejiang Medicine (600216)?

As of Nov 20, 2026, Zhejiang Medicine (600216) is trading at a price of 10.11 CNY, with a previous close of 10.41 CNY. The stock has fluctuated within a day range of 10.10 CNY to 10.33 CNY, while its 52-week range spans from 10.10 CNY to 18.58 CNY.

What Is Zhejiang Medicine (600216) Price Target According to Analysts?

The average 12-month price target for Zhejiang Medicine is 14.10 CNY, with a high estimate of 14.5 CNY and a low estimate of 13.7 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +39.47% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.